BeStock  
Stocks › Medical Devices › PACB

Pacific Biosciences of California PACB

US equityMarket cap rank #3366Medical Devices
$2.72 +$0.02 (+0.74%)
Pre-market · Oct 8, 8:10 am ET · After hours $2.70 -0.74%
Open$2.62
Prev close$2.70
Day range$2.50 – $2.74
Volume20.37M
Market cap$845.46M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$2.08-23.5% vs. price
  • Buy 50%
  • Hold 25%
  • Sell 25%
Low $1.25Now $2.72Avg $2.08High $3.00

Recent rating changes

The last 20 actions on file set price targets from $1.00 to $3.00, averaging $2.31.

DateFirmRatingTarget
7 Oct 2026 Barclays SELL $1.25
11 Sep 2026 CCORF BUY –
17 Aug 2026 CCORF BUY $3.00
6 Aug 2026 TD Cowen BUY $3.00
6 Aug 2026 CCORF BUY $3.00
6 Aug 2026 Piper Sandler HOLD $2.00
5 Aug 2026 Barclays SELL $1.25
8 May 2026 TD Cowen BUY $3.00
8 May 2026 CCORF BUY $3.00
8 May 2026 Piper Sandler HOLD $2.00
8 May 2026 Barclays SELL $1.50
14 Apr 2026 Barclays SELL $1.00
19 Mar 2026 CCORF BUY $3.00
6 Mar 2026 Barclays SELL $1.50
13 Feb 2026 CCORF BUY $3.00
13 Feb 2026 Piper Sandler HOLD $2.00
13 Feb 2026 Barclays HOLD $2.00
12 Feb 2026 TD Cowen BUY $3.00
12 Feb 2026 CCORF BUY $3.00
12 Feb 2026 Guggenheim HOLD –

Discussion

No comments yet — be the first to weigh in on PACB.

Leave a comment

Scroll to Top